Nymox Pharmaceutical Corporation (NYMX) declined -9.36% or -0.16 to $1.55. It is near to 48763 shares traded, which is 59.79% compare to the average total volume 81553. The market cap of NYMX is $104.90 million. The year to date change is -0.44%. The 52 week price range is from $1.25 to $4.15. Price of NYMX have changed -5.52% during last week. It have changed -17.79% over last month, -25.33% over last 3 months, -8.06% over last 6 months and -59.95% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NYMX is 1.99. It is 28.39% above current price. The 200-day Moving Averages for NYMX is 2.17. It is 40.00% above current price. The 52-week High is 4.15. It is 167.74% from the current price. The 52-week Low is 1.25. It is -19.35% from current price.
There are some statistics of NYMX. It is has market cap $104.90 million. The share outstanding is 67.68 million. The average volume is 81553. The percent of top 15 Institution holding is 10.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NYMX is -365.03%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NYMX is -235.08%.